Agreement for the distribution of medical polyolefins

02 February 2017

A European leader in the marketing and distribution of raw material specialities for the plastics, composites, rubber, paints and coatings industries, Velox, has announced its new distribution partnership with Repsol, one of the leading polyolefin producers in Europe. Velox will be distributing medical polyolefins of the new Repsol Healthcare brand - Polypropylene (PP), Polyethylene (PE) and Ethylene Vinyl Acetate (EVA) - for pharmaceutical packaging and medical devices in the following countries: Austria, Belarus, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Israel, Luxemburg, Malta, Netherlands, Norway, Poland, Romania, Russia, Slovakia, Sweden, Switzerland, Turkey, Ukraine and United Kingdom.

Through these medical polyolefins Velox is in the position to offer its customers a more complete and holistic product range for the production of their medical applications. The products meet European & US Pharmacopoeias (USP/EP) requirements, which underlines Repsol’s long-term guarantee, commitment, service and compliance within the Healthcare industry. Velox’ experienced and dedicated medical sales team is pleased to provide high-level technical and commercial advice to integrate these new products combined with the existing medical portfolio into the customer’s value chain.